Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | -0.72% | +0.73% | +0.73% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 22.85M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.89
x | P/E ratio 2025 * |
-1.03
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.21% |
Latest transcript on Lisata Therapeutics, Inc.
1 day | -0.72% | ||
1 week | +0.73% | ||
Current month | +0.73% | ||
1 month | -10.42% | ||
3 months | +3.85% | ||
6 months | +22.77% | ||
Current year | +0.73% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 2.75 | -0.72% | 4,156 |
24-05-06 | 2.77 | -2.81% | 4,071 |
24-05-03 | 2.85 | -2.73% | 9,141 |
24-05-02 | 2.93 | +2.69% | 10,395 |
24-05-01 | 2.853 | +4.51% | 14,108 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.73% | 22.85M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.56% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- LSTA Stock